Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
E Ruiz-Arabi, J Torre-Cisneros, V Aguilera… - Transplantation …, 2024 - Elsevier
Cytomegalovirus (CMV) infection remains a significant challenge in solid organ
transplantation (SOT). The last international consensus guidelines on the management of …
transplantation (SOT). The last international consensus guidelines on the management of …
Recent advances in cytomegalovirus infection management in solid organ transplant recipients
PA Grossi, M Peghin - Current Opinion in Organ Transplantation, 2024 - journals.lww.com
Recent advances in cytomegalovirus infection management in s... : Current Opinion in Organ
Transplantation Recent advances in cytomegalovirus infection management in solid organ …
Transplantation Recent advances in cytomegalovirus infection management in solid organ …
Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized …
N Reiss-Gindi, T Hoffman, T Ruderman, A Atamna… - Infection, 2024 - Springer
Purpose Cytomegalovirus (CMV) is associated with significant morbidity and mortality
among solid organ transplant (SOT) recipients. Strategies for CMV prevention include …
among solid organ transplant (SOT) recipients. Strategies for CMV prevention include …
A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients …
MR Heldman, B Dunn, E Clemens… - Transplant Infectious …, 2024 - Wiley Online Library
The C omparison of A ntiviral P reventative S trategies I n L iver Transplant (CAPSIL) study
showed pre‐emptive therapy (PET) to be superior to antiviral prophylaxis for …
showed pre‐emptive therapy (PET) to be superior to antiviral prophylaxis for …
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
MR Jorgenson, E Meyer, GE Leverson… - Clinical …, 2024 - Wiley Online Library
Purpose Evaluate cytomegalovirus (CMV) post‐prophylaxis surveillance in high‐risk (D+/R‐
) kidney and liver transplant recipients. Methods Adult D+/R‐patients were included if …
) kidney and liver transplant recipients. Methods Adult D+/R‐patients were included if …
Current and future strategies for the prevention and treatment of cytomegalovirus infections in transplantation
MR Heldman, MJ Boeckh… - Clinical Infectious …, 2024 - academic.oup.com
Successful prevention and treatment of cytomegalovirus (CMV) infection remains a central
focus of clinical care in solid organ and allogeneic hematopoietic cell transplantation. Over …
focus of clinical care in solid organ and allogeneic hematopoietic cell transplantation. Over …
Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis
P Arvanitis, MR Davis, D Farmakiotis - Transplantation Reviews, 2024 - Elsevier
Abstract Introduction Despite advancements in Cytomegalovirus (CMV) management, its
impact on graft function, mortality, and cardiovascular (CV) health of organ transplant …
impact on graft function, mortality, and cardiovascular (CV) health of organ transplant …
[HTML][HTML] Antiviral Stewardship in Transplantation
S Bonda, S Trinh, J Hand - Viruses, 2024 - mdpi.com
Though antimicrobial stewardship programs (ASPs) are required for hospitals, the
involvement of transplant recipients in programmatic interventions, protocols, and metrics …
involvement of transplant recipients in programmatic interventions, protocols, and metrics …
Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients
C Fang, C Dong, K Huang, N Wen, Y Chen… - Frontiers in …, 2024 - frontiersin.org
Objective This study aims to explore the factors influencing tacrolimus intrapatient variability
(TAC-IPV) and its association with 1-year post-transplant outcomes in pediatric liver …
(TAC-IPV) and its association with 1-year post-transplant outcomes in pediatric liver …
Re: Association of Cytomegalovirus (CMV) DNAemia With Long-term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention …
TA Yates, N Halliday - Clinical Infectious Diseases, 2024 - academic.oup.com
1. Kumar L, Dasgupta S, Murray-Krezan C, et al. Association of CMV DNAemia with long-
term mortality in a randomized trial of preemptive therapy (PET) and antiviral prophylaxis …
term mortality in a randomized trial of preemptive therapy (PET) and antiviral prophylaxis …